Delivery Order SPE2DR25D2010-SPE2DR26F4ZCD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units, valued at $4,584.29. This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, issued under a competitive procurement with no set-aside designation. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units, with a contract ceiling value of $17,707.09. This is a firm fixed price delivery order with an ultimate completion date of October 22, 2025, and carries no set-aside designation, indicating it was competitively awarded. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,511.19 delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This is a firm fixed-price delivery order with an ultimate completion date of October 22, 2025, and carries no set-aside designation, indicating it was competitively awarded. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $5,080.98 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on August 27, 2025, with completion scheduled for August 28, 2025. This non-set-aside, firm fixed-price delivery order represents a pharmaceutical procurement supporting federal medical supply needs. The award was issued to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units, with a contract ceiling value of $2,828.40. This firm fixed-price delivery order, with an ultimate completion date of November 12, 2025, represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $1,948.10 to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Vemlidy 25 mg tablets (30-count units) with a ceiling value of $7,213.88. This firm fixed-price delivery order, which is not set-aside, represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The vendor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $7,480.24 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on November 10, 2025, with completion scheduled for November 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on July 21, 2025, for the supply of Vemlidy 25 mg tablets (30-count units) with a ceiling value of $5,656.80. This is a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, issued with no set-aside designation, indicating the award was competitively awarded. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Vemlidy 25 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $3,649.19. This non-set-aside delivery order, with an ultimate completion date of August 29, 2025, will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single pharmaceutical product delivery supporting federal medical...
- SPE2DR25D2010Indefinite Delivery Contract
- SPE2DR25D2010-SPE2DR26F4ZCDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $2,703.17 and an ultimate completion date of December 3, 2025. The award was not set-aside and was competitively awarded, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's $1 billion IDC with DLA functions as a comprehensive global pharmaceutical support vehicle enabling the supply of diverse pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems worldwide. This delivery order represents a discrete transaction within that broader contract vehicle to support ongoing federal pharmaceutical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 12/1/25 |